Need professional-grade analysis? Visit stockanalysis.com
$15.10B
98.24
946
N/A
Inner Mongolia Furui Med Sci (300049) trades on SHE in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY57.45, up 0.82% from the previous close.
Over the past year, 300049 has traded between a low of CNY29.85 and a high of CNY87.87. The stock has gained 83.1% over this period. It is currently 34.6% below its 52-week high.
Inner Mongolia Furui Med Sci has a market capitalization of $15.10B, with a price-to-earnings ratio of 98.24.
Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company also engages in the research and development and sales of diagnostic equipment and related medical services. It offers FibroScan series of liver fibrosis diagnostic instruments; FibroMeter series of blood test analysis tools for evaluating chronic liver disease; and FibroView data management software. It provides digital health management services; compound turtle shell softening liver tablets; and prescription drugs. The company was formerly known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company. Inner Mongolia Furui Medical Science Co., Ltd. was founded in 1998 and is headquartered in Beijing, China.
Side-by-side comparison against top Healthcare peers.